Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
24,183
Sort by:
Virtual Clinical Trials Market Forecasts to 2034 – Global Analysis By Study Design (Interventional Trials, Observational Trials, and Expanded Access Trials), Trial Model, Phase, Therapeutic Area, Technology, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Virtual Clinical Trials Market is accounted for $11.4 billion in 2026 and is expected to reach $36.8 billion by 2034, growing at a CAGR of 15.7% during the for...
June 2026
200 pages
Global KSK7653 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global KSK7653 market size is expected to reach $ 321 million by 2032, rising at a market growth of 24.1% CAGR during the forecast period (2026-2032). In 2025, global HSK7653 production reached ap...
June 2026
88 pages
Vaccine Adjuvants Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Diseases, Application, and Region, 2026-2034
US$ 3,999.00
The global vaccine adjuvants market size reached USD 1,223.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,987.6 Million by 2034, exhibiting a growth rate (CAGR) of 1...
June 2026
136 pages
Bleeding Disorders Treatment Market Report by Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, and Others), Drug Class (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Stores), End User (Hospitals, Clinics, Academic and Research Institutes), and Region 2026-2034
US$ 3,999.00
The global bleeding disorders treatment market size reached USD 16.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.3 Billion by 2034, exhibiting a growth rate (CAGR)...
June 2026
144 pages
Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2026-2034
US$ 3,999.00
The global intravenous (IV) ibuprofen market size reached USD 7.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.6 Billion by 2034, exhibiting a growth rate (CAGR) of...
June 2026
149 pages
Pharmaceutical Fine Chemicals Market Report by Type (Proprietary, Non-proprietary), Product (Active Ingredients, Basic Building Blocks, Advanced Intermediates), Size (Big Molecules, Small Molecules), Application (Cardiovascular, Neurological, Oncological, Respiratory, Gastrointestinal, Musculoskeletal, and Others), and Region 2026-2034
US$ 3,999.00
The global pharmaceutical fine chemicals market size reached USD 157.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 250.6 Billion by 2034, exhibiting a growth rate (CA...
June 2026
143 pages
Global GP681 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global GP681 market size is expected to reach $ 195 million by 2032, rising at a market growth of 7.9% CAGR during the forecast period (2026-2032). GP681 is a novel oral antiviral drug targeting i...
June 2026
92 pages
Global IMP4279 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global IMP4279 market size is expected to reach $ 50.90 million by 2032, rising at a market growth of 8.7% CAGR during the forecast period (2026-2032). IMP4279 is a novel DNA damage response pathw...
June 2026
93 pages
